Gavi Leap
Since the middle of 2024, Gavi began a process of re-examining every aspect of the way it works to prepare for its next strategic period. Learn more about this transformation known as the ‘Gavi Leap’.
Learn more
Since the middle of 2024, Gavi began a process of re-examining every aspect of the way it works to prepare for its next strategic period. Learn more about this transformation known as the ‘Gavi Leap’.
Learn moreGavi's five-year plan
Learn more about the five-year strategy setting out the vision and goals that drive our work.
Learn more about the five-year strategy setting out the vision and goals that drive our work.
Latest news
View allPreventive cholera vaccination resumes as global supply reaches critical milestone
First preventive campaign in over three years launches in Mozambique, with others planned in Bangladesh and the Democratic Republic of the Congo.
Gavi announces new partnerships to accelerate innovation and expand access to immunisation
New private-sector and philanthropic partnerships will help Gavi scale innovation, strengthen healthcare and reach underserved communities.
Gavi CEO calls for global health leap
Gavi CEO Dr Sania Nishtar, writing in The Lancet, sets out a framework for radical reform of global health institutions.
What is VaccinesWork?
VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.
Learn more
VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.
Learn moreVaccinesWork latest
Major study confirms COVID-19 vaccination does not affect fertility
Extensive population data from Sweden supports the safety of COVID-19 vaccines for women of childbearing age.
How community health workers are improving vaccine delivery in Africa
Grassroots health workers are uniquely positioned to boost the reach of preventive healthcare – but to do that, they need more support.
Could a new vaccine help stop the deadly MERS coronavirus?
Early trial results suggest an experimental vaccine gives long-lasting immunity against the Middle East respiratory syndrome (MERS) coronavirus.
